Description
Atomoxetine is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD). The brand name is Strattera. The initial therapeutic effects of atomoxetine usually take 2–4 weeks to become apparent. There has been some suggestion that atomoxetine might be a helpful adjunct in people with major depression, especially in cases where ADHD occurs comorbidly to major depression.
Product information
CAS Number: 82248-59-7
Molecular Weight: 291.82
Formula: C17H22ClNO
Synonym:
Tomoxetine hydrochloride
LY 139603
(R)-Tomoxetine hydrochloride
Chemical Name: methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine hydrochloride
Smiles: Cl.CC1=CC=CC=C1O[C@H](CCNC)C1C=CC=CC=1
InChiKey: LUCXVPAZUDVVBT-UNTBIKODSA-N
InChi: InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.